Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;7(6):202-208.
doi: 10.14740/cr507w. Epub 2016 Dec 31.

The Prevalence of Metabolic Syndrome in Coronary Artery Disease Patients

Farzaneh Montazerifar  1 , Ahmad Bolouri  2 , Milad Mahmoudi Mozaffar  3 , Mansour Karajibani  4
Affiliations

The Prevalence of Metabolic Syndrome in Coronary Artery Disease Patients

Farzaneh Montazerifar et al. Cardiol Res. 2016 Dec.

Abstract

Background: Metabolic syndrome (MetS) is a worldwide health problem, which is growing in Iranian adults. MetS is associated with risk of type 2 diabetes and coronary artery disease (CAD). In this study, we aimed to investigate the prevalence of MetS and its individual components in CAD patients.

Methods: This cross-sectional study was performed on 200 CAD patients who had undergone elective coronary angiography at the cardiology department. Anthropometric indices including waist circumference (WC) and body mass index were measured. Blood samples were obtained to determine glucose and lipid profile. MetS components were defined according to the modified Adult Treatment Panel III (ATP III) criteria.

Results: The prevalence of MetS among patients was 49.5% (women: 55.9%; men: 40.2%; P < 0.05). The prevalence increased with age. The low high-density lipoprotein-cholesterol (low HDL-C) (84.8%), high fasting blood glucose (high FBG) (77.8%) and high WC (75.8%) were the most prevalent risk factors in CAD patients with MetS.

Conclusions: Recent data indicate that the dyslipidemia, hyperglycemia and abdominal obesity are crucial predictors of MetS in CAD patients. Further prospective studies are recommended for more clarification.

Keywords: Coronary artery disease; Metabolic syndrome; Prevalence.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fiuza M. [Metabolic syndrome and coronary artery disease] Rev Port Cardiol. 2012;31(12):779–782. doi: 10.1016/j.repce.2012.10.004. - DOI - PubMed
    1. Hajian-Tilaki K. Metabolic syndrome and its associated risk factors in Iranian adults: A systematic review. Caspian J Intern Med. 2015;6(2):51–61. - PMC - PubMed
    1. Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, Larijani B. et al. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med. 2010;13(5):426–428. - PubMed
    1. Veghari GH, Sedaghat M, Banihashem S, Moharloei P, Angizeh A, Tazik E. et al. The Prevalence of Metabolic Syndrome in the North of Iran. An Epidemiologic Comparative Study. J Cardiovasc Disease Res. 2015;6(4):172–175. doi: 10.5530/jcdr.2015.4.1. - DOI
    1. Neeb ZP, Edwards JM, Alloosh M, Long X, Mokelke EA, Sturek M. Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine. Comp Med. 2010;60(4):300–315. - PMC - PubMed

LinkOut - more resources